IL111186A0 - Process for the preparation of microspheres and microspheres made thereby - Google Patents

Process for the preparation of microspheres and microspheres made thereby

Info

Publication number
IL111186A0
IL111186A0 IL11118694A IL11118694A IL111186A0 IL 111186 A0 IL111186 A0 IL 111186A0 IL 11118694 A IL11118694 A IL 11118694A IL 11118694 A IL11118694 A IL 11118694A IL 111186 A0 IL111186 A0 IL 111186A0
Authority
IL
Israel
Prior art keywords
microspheres
preparation
microspheres made
Prior art date
Application number
IL11118694A
Other versions
IL111186A (en
Original Assignee
Univ Bar Ilan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bar Ilan filed Critical Univ Bar Ilan
Priority to IL11118694A priority Critical patent/IL111186A/en
Publication of IL111186A0 publication Critical patent/IL111186A0/en
Priority to AU41934/96A priority patent/AU4193496A/en
Priority to DE19581787T priority patent/DE19581787T1/en
Priority to US08/809,957 priority patent/US6103379A/en
Priority to PCT/US1995/012988 priority patent/WO1996011054A2/en
Publication of IL111186A publication Critical patent/IL111186A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/10—Magnetic particle immunoreagent carriers the magnetic material being used to coat a pre-existing polymer particle but not being present in the particle core
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/86—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids the coating being pre-functionalised for attaching immunoreagents, e.g. aminodextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ceramic Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
IL11118694A 1994-10-06 1994-10-06 Process for the preparation of microspheres and microspheres made thereby IL111186A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL11118694A IL111186A (en) 1994-10-06 1994-10-06 Process for the preparation of microspheres and microspheres made thereby
AU41934/96A AU4193496A (en) 1994-10-06 1995-10-05 Process for the preparation of microspheres and microspheres made thereby
DE19581787T DE19581787T1 (en) 1994-10-06 1995-10-05 Process for the production of microspheres and microspheres produced thereby
US08/809,957 US6103379A (en) 1994-10-06 1995-10-05 Process for the preparation of microspheres and microspheres made thereby
PCT/US1995/012988 WO1996011054A2 (en) 1994-10-06 1995-10-05 Process for the preparation of microspheres and microspheres made thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11118694A IL111186A (en) 1994-10-06 1994-10-06 Process for the preparation of microspheres and microspheres made thereby

Publications (2)

Publication Number Publication Date
IL111186A0 true IL111186A0 (en) 1994-12-29
IL111186A IL111186A (en) 1999-09-22

Family

ID=11066612

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11118694A IL111186A (en) 1994-10-06 1994-10-06 Process for the preparation of microspheres and microspheres made thereby

Country Status (4)

Country Link
AU (1) AU4193496A (en)
DE (1) DE19581787T1 (en)
IL (1) IL111186A (en)
WO (1) WO1996011054A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747669B1 (en) * 1996-04-22 1998-05-22 Rhone Poulenc Chimie PROCESS FOR THE PREPARATION OF HOLLOW SILICA PARTICLES
DE69810080T2 (en) 1997-01-21 2003-10-09 Grace W R & Co SILICON DIOXIDE ADSORBENT ON MAGNETIC SUPPORT
JP4092070B2 (en) * 2000-11-27 2008-05-28 独立行政法人科学技術振興機構 Organic-inorganic composite using sugar derivative and method for producing metal oxide
GB0107563D0 (en) 2001-03-27 2001-05-16 Amersham Pharm Biotech Uk Ltd NO synthase assay particles and method
US6890703B2 (en) 2002-03-06 2005-05-10 International Business Machines Corporation Preparation of crosslinked particles from polymers having activatible crosslinking groups
US20040197819A1 (en) * 2003-04-03 2004-10-07 Kimberly-Clark Worldwide, Inc. Assay devices that utilize hollow particles
DE10355409A1 (en) 2003-11-25 2005-06-30 Magnamedics Gmbh Spherical, magnetic silica gel carriers with increased surface area for the purification of nucleic acids
US9278866B2 (en) 2005-08-10 2016-03-08 The Procter & Gamble Company Hollow silica particles, compositions comprising them, and methods for making same
US20130040817A1 (en) * 2010-04-20 2013-02-14 Basf Se Capsule comprising active ingredient
US10557846B2 (en) * 2012-11-16 2020-02-11 Quantamatrix Inc. Encoded polymeric microparticles
DE102016105122B4 (en) * 2016-03-18 2019-07-11 Bundesrepublik Deutschland, Vertreten Durch Den Bundesminister Für Wirtschaft Und Energie, Dieser Vertreten Durch Den Präsidenten Der Bundesanstalt Für Materialforschung Und -Prüfung (Bam) A method of synthesizing hybrid core-shell microparticles comprising a polymer core and a controlled-surface silica shell
CN110508222B (en) * 2019-08-02 2022-03-18 复旦大学 Monodisperse core-shell microsphere with mesoporous silica shell and preparation method thereof
CN113578214B (en) * 2021-08-11 2023-08-11 天津博蕴纯化装备材料科技有限公司 Micron-sized porous magnetic microsphere and preparation method and application thereof
CN115893980B (en) * 2022-09-30 2023-08-11 安徽华仕新材有限公司 Process for preparing porous support ceramic by using nodulizer micropowder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564336A1 (en) * 1984-05-16 1985-11-22 Ohayon Hanania Device for separating blood and producing serum
FR2624873B1 (en) * 1987-12-18 1992-01-10 Rhone Poulenc Chimie MAGNETISABLE COMPOSITE PARTICLES BASED ON CROSSLINKED ORGANOPOLYSILOXANE, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN BIOLOGY
ATE225512T1 (en) * 1991-03-20 2002-10-15 Marconi Optical Components Ltd SEPARATION PROCESS
GB9211822D0 (en) * 1992-06-04 1992-07-15 Tioxide Group Services Ltd Composite pigmentary material

Also Published As

Publication number Publication date
WO1996011054A2 (en) 1996-04-18
DE19581787T1 (en) 1997-11-27
IL111186A (en) 1999-09-22
WO1996011054A3 (en) 1996-05-23
AU4193496A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
IL116024A0 (en) Functionalized polyorganisiloxanes and one of the processes for the preparation thereof
EP0708482A3 (en) BiCDMOS process technology and structures
EP0699695A3 (en) Process for the preparation of copolyacetals
IL116025A0 (en) Functionalized polyorganisiloxanes and one of the processes for the preparation thereof
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
EP0761718A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
IL111186A0 (en) Process for the preparation of microspheres and microspheres made thereby
IL109656A0 (en) Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
GB9509826D0 (en) Process for the preparation of imidazolutidine
EP0761721A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
SG46689A1 (en) Process for the preparation of 2-h-heptafluoropropane
GB9603728D0 (en) Eggshell catalyst and process for preparation of the same
HU216713B (en) Cyclic-acetals and process for their preparation
EP0484546A4 (en) Microcapsule and method of making the same
EP0761719A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
GB9310781D0 (en) Preparation of microparticles
EP0770598A3 (en) Process for the preparation of carbazates
EP0761720A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
GB9416728D0 (en) Process for the preparation of 4-chloro-2-cyclopropylcarhbonylaniline
IL117191A0 (en) Process for the preparation of oxazolidinones and their use
ZA9510894B (en) Process for the preparation of chloromethylpyridines
IL116493A0 (en) Process for the preparation of sameridine
OA09875A (en) Deep-drilling cement and process for the preparation thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees